TRPM2 and acute myeloid leukemia: In U937 cells, the depletion of TRPM2 substantially inhibits AML cell proliferation and promotes their sensitivity to doxorubicin through mitochondrial dysfunction, autophagy impairment, production of reactive oxygen species (ROS), and reduction of antioxidant molecules.